The Department of Health and Human Services announced Tuesday that it was awarding a contract worth up to $812 million to Richmond-based Phlow Corp., to manufacture pharmaceutical ingredients, chemical compounds and generic drugs needed to soften or prevent drug shortages in the U.S.
↧